ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176503 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176503; 2) Community: the network communities that were significantly associated with the response to NSC 176503; 3) Molecule: the relationships between components within communities and NSC 176503; 4) MDR: the compounds that were significantly associated with the NSC 176503.

NSC Compound Enrichment Correlation
NSC 719412 Null 0.0446159312763229 -0.096014457
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.0446159312763229 0.3206588
NSC 728037 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 0.0446159312763229 0.43711321
NSC 732317 6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide 0.0446159312763229 0.51595223
NSC 732844 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-fluorobenzene 0.0446159312763229 0.43715882
NSC 735372 Bis{(5,6-dihydro-5,11-diketo-2,3-dimethoxy-11H-indeno[1,2-c] isoquinoline)-6-ethylamino}propane Bis(trifluoroacetate) 0.0446159312763229 0.27199665
NSC 736493 Indenoisoquinoline derivative 0.0446159312763229 0.22896104
NSC 758664 Sirolimus [USAN] 0.0446159312763229 -0.12913348
NSC 758682 ARTENIMOL 0.0446159312763229 0.49092601
NSC 89822 Null 0.0446159312763229 0.4166208
Total:176  Current:150    [First] [Prev] [Next] [Last]